A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Avatrombopag Impurity 17 - Request Quote

Picture of Avatrombopag Impurity 17

Avatrombopag Impurity 17

SZ CAT No:SZ-A084026
CAS No
NA
Mol.F.
C6H3Br2ClOS
Mol.Wt.
318.4
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Avatrombopag Impurity 17 is chemically 2,2-Dibromo-1-(4-chlorothiophen-2-yl)ethan-1-one. Avatrombopag Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Avatrombopag Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Avatrombopag.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Avatrombopag Impurity 17

Purchase Avatrombopag Impurity 17

Avatrombopag Impurity 17 suppliers

Avatrombopag Impurity 17 manufacturers

Avatrombopag Impurity 17 price

Order Avatrombopag Impurity 17

Enquire Avatrombopag Impurity 17

Avatrombopag Impurity 17 cost

Avatrombopag Impurity 17 Supplier

Avatrombopag Impurity 17 Distributor

Avatrombopag Impurity 17 for Method Validation

Avatrombopag Reference Standard

Avatrombopag Impurity 17 for ANDA Filing

Avatrombopag Impurity 17 for Forced Degradation Studies

Avatrombopag Impurity 17 Identification Standards

Avatrombopag Impurity 17 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,